Uptravi (selexipag) Receives FDA Approval for Intravenous Use in Adult Patients with Pulmonary Arterial Hypertension (PAH)
TITUSVILLE, N.J. – July 30, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. […]
Moderna to create vaccine to fight both COVID-19, flu Fox News medical contributor Dr. Janette Nesheiwat says Moderna developments are […] Surgeons in Chicago have given a new set of lungs to a young woman with severe lung damage from the […] A targeted drug has been accepted for routine use on the NHS in England for some adults with untreated, advanced […] September 5, 2018 – Pfizer Inc. (NYSE:PFE) today announced its investigational oral Janus kinase 3 (JAK3) inhibitor PF-06651600 received Breakthrough […]Receives
8-year-old accidentally receives COVID-19 vaccine
Coronavirus survivor in US receives double lung transplant
One lung cancer drug receives NHS England approval, while another is rejected
Pfizer Receives Breakthrough Therapy Designation from FDA for PF-06651600, an oral JAK3 Inhibitor, for the Treatment of Patients with Alopecia Areata